Pakistan has reportedly lost around $40 billion since India suspended trade, according to a business-linked assessment cited by outlets. The figure is presented as the overall impact on Pakistan’s economy following the halt.
One area highlighted in the coverage is Pakistan’s dependence on Indian inputs, particularly for its pharmaceutical industry. NDTV says pharmaceutical manufacturers rely on raw materials sourced from India, and adds that switching to or relying on available Indian supplies could produce annual savings estimated at USD 2 billion to USD 3 billion.
Other outlets largely repeat the $40 billion cost claim without adding detailed industry breakdowns in the provided summaries, focusing instead on the headline economic figure tied to the trade suspension. Differences in framing appear mainly in how much context is supplied about specific sectors and potential savings rather than on the core loss estimate.
